In the field of cardiovascular disease research, biomarkers such as C-reactive protein (CRP), interleukin (IL), and tumor necrosis factor-alpha (TNF-α) are considered to be associated with poor prognosis in patients with hypertension or coronary heart disease (6). This evidence concerns the gene CRP and coronary artery disorder.